Table: Brightpath Biotherapeutics -2025/26 parent forecast

BrightPath Biotherapeutics Co

13/03/2026 06:31

Mar 13 (Reuters) -
              Brightpath Biotherapeutics Co., Ltd.     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2026      Mar 31, 2026   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales            0 mln             0 mln      
  Operating      loss 1.32         loss 1.18    
  Recurring      loss 1.31         loss 1.16    
  Net            loss 1.31         loss 1.17    
  EPS         loss 11.75 yen    loss 12.88 yen  
 
  NOTE - Brightpath Biotherapeutics Co., Ltd..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T